Background. A single nucleotide polymorphism (SNP) in the catechol-o-methyltransferase (COMT) gene, Val158Met (rs4680), influences cognition in the general population. However, its role in stroke recovery is unclear. In this study, we evaluated the association of Val158Met SNP with stroke functional outcome and recovery. Methods. This is a retrospective study. The MGB Biobank was queried for 570 individuals with stroke and available genomics data. A subset of 164 was curated based on their admission to Spaulding Rehabilitation Hospital (SRH) for inpatient rehabilitation, meeting inclusion/exclusion criteria and receiving a rehabilitation program tailored to their individual needs and goals. Functional independent measures (FIM) were assessed upon admission to SRH and discharge. Multiple tests were performed to identify related clinic characteristics associated with functional outcome, recovery, and independence dichotomization. Logistic and linear regression models adjusted for covariate variables were used to evaluate the association between COMT Val58Met and functional outcome and recovery. Results. Genotype analysis confirmed that COMT Met/Met frequency was higher compared to Val allele frequency in high cognitive functional outcome. Furthermore, after adjusting for covariate variables, COMT Met/Met led to positive cognitive outcome (P = 0.029; OR = 2.43 [0.19-4.56)] in comprehension (P = 0.013, OR = 0.62 [0.15-1.08]) and expression (P = 0.007, OR = 0.74 [0.19-1.25]). In independence dichotomization analysis, high cognitive outcomes (P = 0.04, OR = 0.81 [1.04-4.82]) were found in the sub-domains of comprehension (P = 0.002, OR = 1.21 [1.56-7.17]), expression (P = 0.03, OR = 0.83 [1.08-4.83]), problem solving (P = 0.02, OR = 0.88 [1.15-5.06]), and memory (P = 0.039, OR = 0.78 [1.04-4.58]). Conclusion. Stroke patients with COMT Met/Met were associated with improved cognition, comprehension, and expression functional outcomes..
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820. doi:10.1016/S1474-4422(21)00252-0
2.
ChenZWuXZhouD, et al. Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis. Neurol Sci. 2022;43(2):1087-1096. doi:10.1007/s10072-021-05359-z
LevineDAGaleckiATLangaKM, et al. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314(1):41-51. doi:10.1001/jama.2015.6968
5.
GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973-1003. doi:10.1016/S1474-4422(24)00369-7
6.
ValančienėJMelaikaKŠliachtenkoAŠiaurytė-JurgelėnėKEkkertAJatužisD.Stroke genetics and how it Informs novel drug discovery. Expert Opin Drug Discov. 2024;19(5):553-564. doi:10.1080/17460441.2024.2324916
7.
O’DonnellMJChinSLRangarajanS, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761-775.
8.
TuWJZhaoZYinP, et al. Estimated burden of stroke in China in 2020. JAMA Netw Open. 2023;6(3):e231455. doi:10.1001/jamanetworkopen.2023.1455
9.
CarnwathTPDemelSLPrestigiacomoCJ.Genetics of ischemic stroke functional outcome. J Neurol. 2024;271(5):2345-2369. doi:10.1007/s00415-024-12263-x
10.
StanneTMTjärnlund-WolfAOlssonSJoodKBlomstrandCJernC.Genetic variation at the BDNF locus: evidence for association with long-term outcome after ischemic stroke. PLoS One. 2014;9(12):e114156. doi:10.1371/journal.pone.0114156
11.
LiuBHeWLiuD.Functional BDNF rs7124442 variant regulated by miR-922 is associated with better short-term recovery of ischemic stroke. Ther Clin Risk Manag. 2019;15:1369-1375. doi:10.2147/TCRM.S22553
12.
SantoroMSiottoMGermanottaM, et al. BDNF rs6265 polymorphism and its methylation in patients with stroke undergoing rehabilitation. Int J Mol Sci. 2020;21(22):8438. doi:10.3390/ijms21228438
13.
HanZQiLXuQ, et al. BDNF met allele is associated with lower cognitive function in poststroke rehabilitation. Neurorehabil Neural Repair. 2020;34(3):247-259. doi:10.1177/1545968320902127
14.
WeiLKAuAMenonS, et al. Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and Ischemic stroke: meta-analysis. J Stroke Cerebrovasc Dis. 2017;26(11):2482-2493. doi:10.1016/j.jstrokecerebrovasdis.2017.05.048
15.
WitteAVFlöelA.Effects of COMT polymorphisms on brain function and behavior in health and disease. Brain Res Bull. 2012;88(5):418-428. doi:10.1016/j.brainresbull.2011.11.012
16.
StahlSM.Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 4th edn. Cambridge University Press; 2013.
17.
SheldrickAJKrugAMarkovV, et al. Effect of COMT val158met genotype on cognition and personality. Eur Psychiatry. 2008;23(6):385-389. doi:10.1016/j.eurpsy.2008.05.002
18.
MavridisAReinholdssonMSunnerhagenKSAbzhandadzeT.Predictors of functional outcome after stroke: sex differences in older individuals. J Am Geriatr Soc. 2024;72(7):2100-2110. doi:10.1111/jgs.18963
19.
WinkelmeierLKniepHFaizyT, et al. Age and functional outcomes in patients with large ischemic stroke receiving endovascular thrombectomy. JAMA Netw Open. 2024;7(8):e2426007. doi:10.1001/jamanetworkopen.2024.26007
20.
NgYSSteinJNingMBlack-SchafferRM.Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke. 2007;38(8):2309-2314. doi:10.1161/STROKEAHA.106.475483
21.
RovitoCParkAGoldsteinRZafonteRBlack-SchafferRSchneiderJC.A retrospective cohort comparing left and right middle cerebral artery ischemic stroke functional outcomes in acute inpatient rehabilitation. PM & R. 2021;13(7):666-673. doi:10.1002/pmrj.12465
22.
KawanoHJohnoTToriiM, et al. Predictable value of functional independence measure differs between anterior and posterior circulation ischemic strokes. Eur Neurol. 2018;80(5-6):313-320. doi:10.1159/000499132
23.
JacobMAEkkerMSAllachY, et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults-a worldwide meta-analysis: the GOAL initiative. Neurology. 2022l;98(6):e573-e588. doi:10.1212/WNL.0000000000013195
24.
WangXHuangYChenY, et al. The relationship between body mass index and stroke: a systemic review and meta-analysis. J Neurol. 2022;269(12):6279-6289. doi:10.1007/s00415-022-11318-1
25.
FreemanCBloughARotichDCurlAEickmeyerSM.The obesity paradox may not lead to functional gains in stroke patients undergoing acute inpatient rehabilitation. PM & R. 2022;14(8):931-938. doi:10.1002/pmrj.12671
26.
BoutinNTSchecterSBPerezEF, et al. The evolution of a large biobank at mass general Brigham. J Pers Med. 2022;12(8):1323. doi:10.3390/jpm12081323
27.
KeithRAGrangerCVHamiltonBBSherwinFS.The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.
28.
AnchetaJHusbandMLawDRedingM.Initial functional independence measure score and interval post stroke help assess outcome, length of hospitalization, and quality of care. Neurorehabil Neural Repair. 2000;14(2):127-134. doi:10.1177/154596830001400205
29.
García-RudolphAWrightMGarcíaL, et al. Long-term prediction of functional independence using adjusted and unadjusted single items of the functional independence measure (FIM) at discharge from rehabilitation. J Spinal Cord Med. 2024;47(5):649-660. doi:10.1080/10790268.2023.2183326
30.
HamiltonBBLaughlinJAFiedlerRCGrangerCV.Interrater reliability of the 7-level functional independence measure (FIM). Scand J Rehabil Med. 1994;26(3):115-119.
HuZMLuoLLLiLDaiSDZhangHGLiuRZ.Indigenization of the median of markers for Down syndrome screening based on statistical analysis of medical big data. Taiwan J Obstet Gynecol. 2020;59(4):556-564. doi:10.1016/j.tjog.2020.05.015
33.
LindgrenABraunRMajersikJJ, et al. International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery. Int J Stroke. 2022;17(3):260-268.
ChamorroADirnaglUUrraXPlanasAM.Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 2016;15:869-881
36.
Bernardo-CastroSSousaJABrasA, et al. Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol. 2020;11:594672.
37.
SakaiSShichitaT.Inflammation and neural repair after ischemic brain injury. Neurochem Int. 2019;130:104316.
38.
CorbettDCarmichaelSTMurphyTH, et al. Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: consensus-based core recommendations from the stroke recovery and rehabilitation roundtable translational working group. Neurorehabil Neural Repair. 2017;31:699-707.
39.
CarmichaelSTArchibequeILukeLNolanTMomiyJLiS.Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp Neurol. 2005;193:291-311.
40.
HeitschLIbanezLCarreraC, et al. Early neurological change after ischemic stroke is associated with 90-day outcome. Stroke. 2021;52:132-141.
41.
MontanerJRamiroLSimatsA, et al. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke. Nat Rev Neurol. 2020;16:247-264.
42.
RangarajuSFrankelMJovinTG.Prognostic value of the 24-hour neurological examination in anterior circulation ischemic stroke: a post hoc analysis of two randomized controlled stroke trials. Interv Neurol. 2016;4:120-129.
43.
DharR.Automated quantitative assessment of cerebral edema after ischemic stroke using CSF volumetrics. Neurosci Lett. 2020;724:134879. doi:10.1016/j.neulet.2020.134879
44.
OngCJChatzidakisSOngJJFeskeS.Updates in management of large hemispheric infarct. Semin Neurol. 2024;44(3):281-297. doi:10.1055/s-0044-1787046
45.
RanlundSCalafatoSThygesenJH, et al. A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. Am J Med Genet B Neuropsychiatr Genet. 2018;177(1):21-34. doi:10.1002/ajmg.b.32581
46.
JianXFornageM.Imaging endophenotypes of stroke as a target for genetic studies. Stroke. 2018;49:1557-1562.
47.
DawsonJLiuCYFranciscoGE, et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet. 2021;397:1545-1553.
48.
SöderholmMPedersenALorentzenE, et al. International Stroke Genetics Consortium, the NINDS-SiGN Consortium, and the Genetics of Ischaemic Stroke Functional Outcome (GISCOME) Network. Genome-wide association meta-analysis of functional outcome after ischemic stroke. Neurology. 2019;92(12):e1271-e1283. doi:10.1212/WNL.0000000000007138
49.
Mola-CaminalMCarreraCSoriano-TarragaC, et al. PATJ low frequency variants are associated with worse ischemic stroke functional outcome. Circ Res. 2019;124:114-120.
50.
PfeifferDChenBSchlichtK, et al. CADISP; GISCOME; SiGN studies; and ISGC. Genetic imbalance is associated with functional outcome after ischemic stroke. Stroke. 2019;50(2):298-304. doi:10.1161/STROKEAHA.118.021856
51.
LeeJMFernandez-CadenasILindgrenAG.Using human genetics to understand mechanisms in ischemic stroke outcome: from early brain injury to long-term recovery. Stroke. 2021;52(9):3013-3024. doi:10.1161/STROKEAHA.121.032622
52.
LappalainenTScottAJBrandtMHallIM.Genomic analysis in the age of human genome sequencing. Cell. 2019;177(1):70-84. doi:10.1016/j.cell.2019.02.032
53.
HebbringS.Genomic and phenomic research in the 21st century. Trends Genet. 2019;35:29-41.
54.
ZhangYChengYJiangWYeYLuQZhaoH.Comparison of methods for estimating genetic correlation between complex traits using GWAS summary statistics. Brief Bioinform. 2021;22(5):bbaa442. doi:10.1093/bib/bbaa442
55.
MeiLGaoYChenM, et al. Overlapping common genetic architecture between major depressive disorders and anxiety and stress-related disorders. Prog Neuro-psychopharmacol Biol Psychiatry. 2022;113:110450. doi:10.1016/j.pnpbp.2021.110450
56.
Soriano-TarragaCLazcanoUGiralt-SteinhauerE, et al. Identification of 20 novel loci associated with ischaemic stroke. Epigenome-wide association study. Epigenetics. 2020;15:988-997.
57.
GillDJamesNEMonoriG, et al. Genetically determined risk of depression and functional outcome after ischemic stroke. Stroke. 2019;50:2219-2222
58.
MirRBhatMJavidJJhaCSaxenaABanuS.Potential impact of COMT-rs4680 G > a gene polymorphism in coronary artery disease. J Cardiovasc Dev Dis. 2018;5(3):38. doi:10.3390/jcdd5030038
59.
SimpsonEHMorudJWinigerV, et al. Genetic variation in COMT activity impacts learning and dopamine release capacity in the striatum. Learn Mem. 2014;21(4):205-214. doi:10.1101/lm.032094.113
60.
FrankMFossellaJ.Neurogenetics and pharmacology of learning, motivation, and cognition. Neuropsychopharmacol. 2011;36:133-152. doi:10.1038/npp.2010.96
61.
MattayVSGoldbergTEFeraF, et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA. 2003;100(10):6186-6191. doi:10.1073/pnas.0931309100
62.
CramerSCParodiLMoslemiZ, et al. STRONG Study Investigators. Genetic variation and stroke recovery: the STRONG study. Stroke. 2024;55(8):2094-2102. doi:10.1161/STROKEAHA.124.047643
63.
AiYLiuYYinM, et al. Interactions between tDCS treatment and COMT Val158Met in poststroke cognitive impairment. Clin Neurophysiol. 2024;158:43-55. doi:10.1016/j.clinph.2023.12.011
64.
HueyEDFremontRManoochehriM, et al. Effect of functional BDNF and COMT polymorphisms on symptoms and regional brain volume in frontotemporal dementia and corticobasal syndrome. J Neuropsychiatry Clin Neurosci. 2020;32(4):362-369. doi:10.1176/appi.neuropsych.19100211
65.
AljuhniRClelandBTRothSMadhavanS.Genetic polymorphisms for BDNF, COMT, and APOE do not affect gait or ankle motor control in chronic stroke: a preliminary cross-sectional study. Top Stroke Rehabil. 2021;28(1):72-80. doi:10.1080/10749357.2020.1762060
66.
KimBRKimHYChunYI, et al. Association between genetic variation in the dopamine system and motor recovery after stroke. Restor Neurol Neurosci. 2016;34(6):925-934. doi:10.3233/RNN-160667
67.
LiepertJHellerABehnischGSchoenfeldA.Catechol-O-methyltransferase polymorphism influences outcome after ischemic stroke: a prospective double-blind study. Neurorehabil Neural Repair. 2013;27(6):491-496. doi:10.1177/1545968313481282
68.
SubramanianSKMorganRTRasmussonCShepherdKMLiCL.Genetic polymorphisms and post-stroke upper limb motor improvement: a systematic review and meta-analysis. J Cent Nerv Syst Dis. 2024;16:11795735241266601. doi:10.1177/11795735241266601
69.
SchachtJP.COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. Pharmacogenomics J. 2016;16(5):430-438. doi:10.1038/tpj.2016.43
70.
AnttilaSHuuhkaKHuuhkaMIlliARontuRLeinonenELehtimäkiT.Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy. Pharmacogenomics J. 2008;8(2):113-116. doi:10.1038/sj.tpj.6500468
71.
BarnettJHJonesPBRobbinsTWMüllerU.Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry. 2007;12(5):502-509. doi:10.1038/sj.mp.4001973
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
